Myles Minter, William Blair research analyst, joins 'Squawk Box' to discuss reports that an experimental personalized cancer vaccine from Merck and Moderna showed positive initial results in its first ...
CNBC's Andrew Ross Sorkin reports on the latest news. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results